Management of gout in the real world: current practice versus guideline recommendations

References

• Doghramji PP, Wortmann RL. Hyperuricemia and gout: new concepts in diagnosis and management. Postgrad Med. 2012;124(6):98–109.
   PubMed Web of Science ®Google Scholar
• Doherty M, Jansen TL, Nuki G, et al. Gout: why is this curable disease so seldom cured? Ann Rheum Dis. 2012;71(11):1765–1770.
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology (Oxford). 2009;48(Suppl 2):ii9–ii14.
   PubMed Web of Science ®Google Scholar
• Becker MA, Fitz-Patrick D, Choi HK, et al. An open-label, 6-month study of allopurinol safety in gout: the LASSO study. Semin Arthritis Rheum. 2015;45:174–183.
   PubMed Web of Science ®Google Scholar
• Khanna D, Khanna PP, Hagerty D. Patients that continue to flare despite apparent optimal urate lowering therapy [abstract]. Arthritis Rheum. 2012;64(suppl 10):140.
   Google Scholar
• Sarawate CA, Patel PA, Schumacher HR, et al. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol. 2006;12(2):61–65.
   PubMed Web of Science ®Google Scholar
• Wei L, Mackenzie IS, Chen Y, et al. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol. 2011;71(4):600–607.
   PubMed Web of Science ®Google Scholar
• Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):186–191.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Andrews LM, Yadao AM, et al. The effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension. Expert Rev Pharmacoecon Outcomes Res. 2012;12(6):821–829.
   PubMed Web of Science ®Google Scholar
• Khanna PP, Nuki G, Bardin T, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey. Health Qual Life Outcomes. 2012;10:117.
   PubMed Web of Science ®Google Scholar
• Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223.
   PubMed Web of Science ®Google Scholar
• Saseen JJ, Agashivala N, Allen RR, et al. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford). 2012;51(11):2004–2012.
   PubMed Web of Science ®Google Scholar
• Scire CA, Manara M, Cimmino MA, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):R101.
   PubMed Web of Science ®Google Scholar
• Wood R, Johnson J, Morlock R. Gout patients treated with conventional urate-lowering therapy: association between disease control and health-related quality of life [abstract]. Ann Rheum Dis. 2014;73(suppl 2):786–787.
   PubMed Web of Science ®Google Scholar
• Wood R, Johnson J, Morlock R. Gout patients treated with conventional urate-lowering therapy: association between disease control and work productivity [abstract]. Ann Rheum Dis. 2014;73(suppl 2):786.
   PubMed Web of Science ®Google Scholar
• Wertheimer A, Morlock R, Becker MA. A revised estimate of the burden of illness of gout. Curr Ther Res Clin Exp. 2013;75:1–4.
   PubMedGoogle Scholar
• Jutkowitz E, Kuntz K, Pizzi L. Cost-effectiveness of urate lowering strategies for the management of gout [abstract]. Arthritis Rheum. 2013;65(suppl 10):856.
   Google Scholar
• Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–3141.
   PubMed Web of Science ®Google Scholar
• Brook RA, Forsythe A, Smeeding JE, et al. Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin. 2010;26(12):2813–2821.
   PubMed Web of Science ®Google Scholar
• Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894–900.
   PubMed Web of Science ®Google Scholar
• Smith EU, Diaz-Torne C, Perez-Ruiz F, et al. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol. 2010;24(6):811–827.
   PubMed Web of Science ®Google Scholar
• Bruderer S, Bodmer M, Jick SS, et al. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol. 2014;66(1):185–196.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, York M, Chaisson CE, et al. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006;33(7):1341–1345.
   PubMed Web of Science ®Google Scholar
• Khanna D, Fitzgerald JD, Khanna PP, et al. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64(10):1431–1446.
   PubMed Web of Science ®Google Scholar
• Richette P, Doherty M, Pascual E et al. Updated EULAR evidence-based recommendations for the management of gout [abstract]. Ann Rheum Dis. 2014;73(suppl 2):783. Abstract SAT0531.
   Google Scholar
• Sivera F, Andres M, Carmona L, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis. 2014;73(2):328–335.
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1312–1324.
   PubMed Web of Science ®Google Scholar
• Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007;46(8):1372–1374.
   PubMed Web of Science ®Google Scholar
• Mikuls TR, MacLean CH, Olivieri J, et al. Quality of care indicators for gout management. Arthritis Rheum. 2004;50(3):937–943.
   PubMed Web of Science ®Google Scholar
• Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther. 2006;8(Suppl 1):S2.
   PubMed Web of Science ®Google Scholar
• Cottrell E, Crabtree V, Edwards JJ, et al. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pract. 2013;14:170.
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Farrar JT, Bilker WB, et al. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford). 2005;44(8):1038–1042.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Shiozawa A, Walsh M, et al. Physician adherence to ACR gout treatment guidelines: perception versus practice. Postgrad Med. 2014;126(3):257–267.
   PubMed Web of Science ®Google Scholar
• Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012;71(9):1490–1495.
   PubMed Web of Science ®Google Scholar
• Lim AY, Shen L, Tan CH, et al. Achieving treat to target in gout: a clinical practice improvement project. Scand J Rheumatol. 2012;41(6):450–457.
   PubMed Web of Science ®Google Scholar
• Rees F, Jenkins W, Doherty M. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis. 2013;72(6):826–830.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health NHBLI Obesity Education Initiative. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health Web site; [ cited 2015 Oct 2]. Available from: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf
   Google Scholar
• Bhole V, De VM, Rahman MM, et al. Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010;62(4):1069–1076.
   PubMed Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005;165(7):742–748.
   PubMed Web of Science ®Google Scholar
• DeMarco MA, Maynard JW, Huizinga MM, et al. Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res (Hoboken). 2011;63(8):1108–1114.
   PubMed Web of Science ®Google Scholar
• Harrold LR, Mazor KM, Negron A, et al. Primary care providers’ knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford). 2013;52(9):1623–1629.
   PubMed Web of Science ®Google Scholar
• Keenan RT, Lehman RA, O’Brien WR. Gout management in primary care vs. rheumatology: evidence for suboptimal treatment [abstract]. Arthritis Rheum. 2009;60(suppl 10):1110.
   Google Scholar
• Wall GC, Koenigsfeld CF, Hegge KA, et al. Adherence to treatment guidelines in two primary care populations with gout. Rheumatol Int. 2010;30(6):749–753.
   PubMed Web of Science ®Google Scholar
• Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063–3072.
   PubMed Web of Science ®Google Scholar
• Cooper T, Prouse PJ. Gout: are we getting it right in primary care? An audit of serum uric acid level measurement and monitoring [abstract]. Ann Rheum Dis. 2013;72:A567.
   Google Scholar
• Reaves E, Arroll B. Management of gout in a South Auckland general practice. J Prim Health Care. 2014;6(1):73–78.
   PubMedGoogle Scholar
• Singh JA, Hodges JS, Toscano JP, et al. Quality of care for gout in the US needs improvement. Arthritis Rheum. 2007;57(5):822–829.
   PubMed Web of Science ®Google Scholar
• Singh JA, Hodges JS, Asch SM. Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis. 2009;68(8):1265–1270.
   PubMed Web of Science ®Google Scholar
• Juraschek SP, Miller ER III, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010. Arthritis Care Res (Hoboken). 2013;65(1):127–132.
   PubMed Web of Science ®Google Scholar
• Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10(1):22.
   PubMed Web of Science ®Google Scholar
• Neogi T, Chen C, Niu J, et al. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med. 2014;127(4):311–318.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global status report on alcohol and health. World Health Organization; 2014 [cited 2015 Oct 2]. Available from: http://www.who.int/substance_abuse/publications/global_alcohol_report/msb_gsr_2014_3.pdf.
   Google Scholar
• Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–834.
   PubMed Web of Science ®Google Scholar
• Becker MA, Chohan S. We can make gout management more successful now. Curr Opin Rheumatol. 2008;20(2):167–172.
   PubMed Web of Science ®Google Scholar
• De Vera MA, Marcotte G, Rai S, et al. Medication adherence in gout: a systematic review. Arthritis Care Res (Hoboken). 2014;66(10):1551–1559.
   PubMed Web of Science ®Google Scholar
• Harrold LR, Andrade SE, Briesacher BA, et al. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 2009;11(2):R46.
   PubMed Web of Science ®Google Scholar
• Sarawate CA, Brewer KK, Yang W, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006;81(7):925–934.
   PubMed Web of Science ®Google Scholar
• Doghramji PP, Edwards NL, McTigue J. Managing gout in the primary care setting: what you and your patients need to know. Am J Med. 2010;123(8):S2.
   PubMed Web of Science ®Google Scholar